Crossmark

Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma

Crossref DOI link: https://doi.org/10.1186/s13287-023-03239-1

Published Online: 2023-02-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Yanlong

Zhang, Xin

Huang, Xuefeng

Tang, Xiaomeng

Zhang, Menghan

Li, Ziyi

Hu, Xiaopeng

Zhang, Min

Wang, Xi

Yan, Yong https://orcid.org/0000-0002-8192-2378
License Information

Text and Data Mining valid from 2023-02-01

Version of Record valid from 2023-02-01
More Information

Article History

Received: 25 July 2022

Accepted: 13 January 2023

First Online: 1 February 2023

Declarations

:

: This study does not include data that require ethical approval and consent.

: Not applicable.

: The authors declare that there is no conflict of interest.

Document is current

Any future updates will be listed below